Estrogen receptor α-negative and progesterone receptor-positive breast cancer: Lab error or real entity?

Pathology and Oncology Research

Volumn 12, Issue 4, 2006, Pages 223-227

  Kiani, Jawad ^a   Khan, Afrasyab ^a   Khawar, Hina ^a   Shuaib, Fawad ^a   Pervez, Shahid ^a,b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

Breast carcinoma; Estrogen receptor (ER) ; Progesterone receptor (PR)

Indexed keywords

ESTROGEN MONOCLONAL ANTIBODY; ESTROGEN RECEPTOR ALPHA; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LABORATORY TEST; LYMPH NODE METASTASIS; MENOPAUSE; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 33847008279     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893416     Document Type: Article

References (39)

1. Ballare C, Bravo, AI, Sorin I, et al: The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer. Cancer 67: 1352-1358, 1991
2. Berger U, McLelland RA, Wilson P, et al: Immunohistochemical determination of estrogen receptor, progesterone receptor and 1, 25-dihydroxvitamin D3 receptor in breast cancer and relationship to prognosis. Cancer Res 51: 239-244, 1991
3. co and MCF-7 breast cancer cells. Mol Endocrinol 3: 22-28, 1989
4. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377, 1957
5. deSombre, ER: Steroid receptors in breast cancer. In: The Breast. (Eds: McDivitt RW Oberman HA, Ozello L and Kaufman N), Williams and Wilkins, Baltimore, 1984, pp149-174
6. Edery M, Goussard J, Dehennin L, et al: Endogenous oestradiol-17ß concentration in breast tumors determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur J Cancer 17: 115-120, 1981
7. Fishman J, Nisselbaum JS, Menendez-Botet CJ, Schwartz MK: Estrogen and estradiol content in human breast tumors: relationship to estradiol receptors. J Steroid Biochem 8: 893-896, 1977
8. Greene GL, Press MF: Steroid receptor structure (including monoclonal antibodies and new methods of determination): structure and dynamics of the estrogen receptor. J Steroid Biochem 24: 1-7, 1986
9. Greene GM, Fitch FW, Jensen EV: Monoclonal antibodies to trophilin: probes for the study of estrogen receptors. Proc Natl Acad Sci USA 77: 157-161, 1980
10. Horwitz KB, McGuire WL: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 253: 2223-2228, 1978
11. Horwitz KB: Cellular heterogeneity and mutant oestrogen receptors in hormone resistant breast cancer. Cancer Surv 14: 41-54, 1992
12. Howat JMT, Harris M, Swindell R, Barnes DM: The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer 51: 263-270, 1985
13. Kiang DT, Kollander R: Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity? J Clin Oncol 5: 662-666, 1987
14. Leclercq G, Heuson JC, Deboel MC, et al: Estrogen and progesterone receptors in human breast cancer. In: Progesterone Receptors in Normal and Neoplastic Tissues. (Eds: McGuire WL, Raynaud J-P, Baulieu E-E), Raven, New York, 1977, pp 141-153
15. Leygue E, Dotzlaw H, Watson PH, Murphy LC: Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res 58: 3197-3201, 1998
16. McGuire WL: Hormone receptors. Their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5: 428-433, 1979
17. McGuire WL, Horwitz KB, Pearson DH, Segaloff A: Current status of estrogen and progesterone receptors in breast cancer. Cancer 39: 2934-2947, 1977
18. McGuire WL: Steroid receptors in human breast cancer. Cancer Res 38: 4289-4291, 1978
19. Nuclear Receptors Nomenclature Committee: A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-163, 1999
20. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884-2888, 1980
21. nd ed, JB Lippincott Co, Philadelphia, PA, 1991, pp 301-325
22. Panko WB, MacLeod RM: Uncharged nuclear receptors for estrogen in breast cancers. Cancer Res 38: 1948-1951, 1978
23. Perrot-Applanat M, Logeat F, Croyer-Picard MT, Milgrom E: Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 116: 147-1483, 1985
24. Pertschuk LP. Kim DS, Kamran Nayer MA, et al: Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Cancer 66: 1663-1670, 1990
25. Pichon MF, Milgrom E: Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumors. Br J Cancer 65: 895-897, 1992
26. Reiner A, Neumeister B, Spona J, et al: Immunocytochemical localization of estrogen and progestin and prognosis in human primary breast cancer. Cancer Res 50: 7057-7061, 1990
27. Saez S, Martin PM, Chouvet CD: Estradiol and progesterone receptors in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res 38: 3468-3473, 1978
28. Sarrif AM, Durant JR: Evidence that estrogen-receptor-negative progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor. Cancer 48: 1215-1220, 1982
29. Savouret J-F, Fridlanski F, Alger M, et al: Origin of the high constitutive level of progesterone receptor in T47-D breast cancer cells. Mol Cell Endocrinol 75: 157-162, 1991
30. Shaaban AM, O'Neill PA, Davies MP, et al: Declining estrogen receptor beta expression defines malignant progression of human breast neoplasia. Am J Surg Pathol 27: 1502-1512, 2003
31. Shapiro CM, Schiffeling D, Bitran JD, et al: Prognostic value of estrogen receptor value in pathologic stage 1 and 2 adenocarcinoma of the breast. J Surg Oncol 19: 119-121, 1982
32. Shigehira S, Makiko H, Masakazu T: Clinical significance of estrogen receptor β in breast cancer. Cancer Chemother Pharmacol 56: s21-s26, 2005
33. Speirs V, Skliris GP, Burdall SE, Carder PJ: Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J Clin Pathol 55: 371-374, 2002
34. Thorpe SM: Immunological quantitation of nuclear receptors in human breast cancers: relation to cytosolic estrogen and progesterone receptors. Cancer Res 47: 1830-1835, 1987
35. Thorsen T: Occupied and unoccupied oestradiol receptor in human breast tumor cytosol. J Steroid Biochem. 24: 1-7, 1986
36. Toft DO, O'Malley BW: Target tissue receptors for progesterone: The influence of estrogen treatment. Endocrinology 90: 1041-1045, 1972
37. Vihko R, Janne O, Kontula K, Syrjala P: Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levels. Int J Cancer 26: 13-21, 1980
38. Watson CS, Medina D, Clark JH: Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumour line. Cancer Res 39: 4098-4104, 1979
39. Zava DT, Chamness GC, Horwitz KB, McGuire WL: Biologically active estrogen receptor in the absence of estrogen. Science 196: 663-664, 1977